Behavioral correlates of HPV vaccine acceptability in the 2007 Health Information National Trends Survey (HINTS)
- PMID: 20142234
- PMCID: PMC2820128
- DOI: 10.1158/1055-9965.EPI-09-0918
Behavioral correlates of HPV vaccine acceptability in the 2007 Health Information National Trends Survey (HINTS)
Abstract
The development of a prophylactic vaccine to prevent infection with oncogenic subtypes of human papillomavirus (HPV) is an important step in reducing cervical cancer incidence and mortality. However, national data indicate that only 37% of 13- to 17-year-old females have initiated the vaccine series. Prior studies have examined demographic, medical history, and psychosocial variables associated with parental HPV vaccine acceptability, although few have investigated the behavioral correlates of vaccine acceptability. The primary purpose of the current study is to report on national acceptability of the HPV vaccine among U.S. adults with female children in the household and to investigate the health behavior correlates of vaccine acceptability. Data were drawn from the 2007 Health Information National Trends Survey (HINTS). The study sample comprised 1,383 adults who reported having a female child under the age of 18 in their household (52% female, 59% white; mean age = 40 years). More than half (58%) reported they would have a daughter get the HPV vaccine, 25% were not sure, and 18% would not have a daughter vaccinated. Behavioral factors significantly associated with lower acceptance of the HPV vaccine included lack of physical activity in the past month (P = 0.002), past year use of complementary or alternative therapies (P = 0.021), and no history of smoking (P = 0.005). These results suggest that behavioral health factors may be associated with vaccine acceptability and further our understanding of how behavioral patterns may contribute to the uptake of new cancer prevention strategies.
Similar articles
-
HPV Vaccine Beliefs and Correlates of Uptake Among Hispanic Women and Their Children on the US-Mexico Border.Cancer Control. 2020 Jan-Dec;27(1):1073274820968881. doi: 10.1177/1073274820968881. Cancer Control. 2020. PMID: 33121254 Free PMC article.
-
Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey.Vaccine. 2012 Mar 23;30(14):2467-74. doi: 10.1016/j.vaccine.2012.01.032. Epub 2012 Jan 19. Vaccine. 2012. PMID: 22266289
-
Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area.Sex Transm Dis. 2011 Mar;38(3):197-204. doi: 10.1097/OLQ.0b013e3181f12dbf. Sex Transm Dis. 2011. PMID: 20838362 Free PMC article.
-
Acceptability of human papillomavirus vaccine for males: a review of the literature.J Adolesc Health. 2010 Feb;46(2):113-23. doi: 10.1016/j.jadohealth.2009.11.199. J Adolesc Health. 2010. PMID: 20113917 Review.
-
Barriers to human papillomavirus vaccine acceptability in Israel.Vaccine. 2013 Nov 22;31 Suppl 8:I53-7. doi: 10.1016/j.vaccine.2013.06.107. Vaccine. 2013. PMID: 24229720 Review.
Cited by
-
Global parental acceptance, attitudes, and knowledge regarding human papillomavirus vaccinations for their children: a systematic literature review and meta-analysis.BMC Womens Health. 2024 Sep 27;24(1):537. doi: 10.1186/s12905-024-03377-5. BMC Womens Health. 2024. PMID: 39334328 Free PMC article.
-
Conceiving an application ontology to model patient human papillomavirus vaccine counseling for dialogue management.BMC Bioinformatics. 2019 Dec 23;20(Suppl 21):706. doi: 10.1186/s12859-019-3193-7. BMC Bioinformatics. 2019. PMID: 31865902 Free PMC article.
-
Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007.Matern Child Health J. 2012 Apr;16 Suppl 1:S102-10. doi: 10.1007/s10995-012-0999-6. Matern Child Health J. 2012. PMID: 22453332
-
Belief that Progress has Been Made in Curing Cancer Varies by Perception of Social Media Health Mis- and Disinformation, Education, Frequency of Social Media Use, and Healthcare System Trust: A Cross-Sectional Study.Cancer Control. 2024 Jan-Dec;31:10732748241289259. doi: 10.1177/10732748241289259. Cancer Control. 2024. PMID: 39334523 Free PMC article.
-
The influence of deductible health plans on receipt of the human papillomavirus vaccine series.J Adolesc Health. 2014 Mar;54(3):275-81. doi: 10.1016/j.jadohealth.2013.12.001. J Adolesc Health. 2014. PMID: 24560035 Free PMC article.
References
-
- Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272–8. - PubMed
-
- Stoler MH. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. Am J Obstet Gynecol. 1996;175:1091–8. - PubMed
-
- Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J. 2003;9:348–59. - PubMed
-
- Wolf JK, Franco EL, Arbeit JM, et al. Innovations in understanding the biology of cervical cancer. Cancer. 2003;98:2064–9. - PubMed
-
- Adams M, Jasani B, Fiander A. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine. 2007;25:3007–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous